Zilucoplan

Ra Pharmaceuticals Inc (NASDAQ: RARX) shares are surging higher Monday morning, reacting to an announcement by the company concerning clinical trial results of its autoimmune disorder drug. What Happened Ra Pharma said topline data from the mid-stage trial of Zilucoplan in patients with...